180 Participants Needed

Intensive Crisis Intervention for Suicidal Thoughts

(ICI Trial)

Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Jennifer Hughes
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The study's purpose is to improve the clinical management of severe crises experienced by youth with psychiatric disorders by examining a brief, evidence-based alternative to inpatient psychiatric care.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Intensive Crisis Intervention for suicidal thoughts?

The study on Intensive Crisis Intervention (ICI) for adolescents showed that this cognitive-behavioral, family-centered treatment is feasible and acceptable, providing an alternative to longer inpatient care for suicidal ideation and behavior. Additionally, the Collaborative Assessment and Management of Suicidality (CAMS), a similar structured intervention, demonstrated significant reductions in suicidal thoughts and related factors in both pilot and controlled-comparison trials, suggesting that structured, suicide-specific interventions can effectively reduce suicide risk.12345

Is Intensive Crisis Intervention for Suicidal Thoughts safe for humans?

There is limited safety data specifically for Intensive Crisis Intervention, but studies highlight the importance of clear definitions and consistent reporting of adverse events (unwanted effects from treatment) in suicide prevention trials. Using multiple methods, like structured follow-up calls, can improve detection of these events, suggesting that safety monitoring is crucial in such interventions.678910

How does Intensive Crisis Intervention differ from other treatments for suicidal thoughts?

Intensive Crisis Intervention is unique because it focuses on immediate, professional support during a suicidal crisis, emphasizing a collaborative relationship and thorough assessment to stabilize emotions and restore functioning. Unlike some other treatments, it may involve family intervention and support systems to address both acute and long-term risks.1112131415

Research Team

JL

Jennifer L Hughes

Principal Investigator

Nationwide Children's Hospital

Eligibility Criteria

This trial is for young individuals experiencing severe mental health crises, such as suicidal thoughts or attempts. Specific details on eligibility criteria are not provided, but typically participants would need to meet certain mental health assessments to qualify.

Inclusion Criteria

I am between 12 and 17 years old.
Be eligible for admission to both YCSU and APIU based on PCD clinician's clinical judgement
Legal guardian must attend the PCD evaluation
See 4 more

Exclusion Criteria

Inability to speak or read English adequately to understand and complete study consent and procedures
I understand the study procedures and am mentally capable of participating.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pilot Testing

Pilot test implementation of Intensive Crisis Intervention (ICI) with adolescents, parents, and providers to refine the intervention.

1 year

Treatment

Participants receive Intensive Crisis Intervention (ICI) or traditional inpatient care. ICI involves 2-3 individual sessions and 1-2 family sessions daily.

4.5 days (ICI) or 9-11 days (APIU)

Follow-up

Participants are monitored for changes in family functioning, suicidal ideation, and other psychiatric symptoms at discharge, 30 days, and 3 months.

3 months

Treatment Details

Interventions

  • Intensive Crisis Intervention
Trial Overview The study is testing a brief, evidence-based Intensive Crisis Intervention (ICI) against the standard care in an Adolescent Psychiatric Inpatient Unit (APIU). It aims to see if ICI can be an effective alternative for managing psychiatric emergencies in youth.
Participant Groups
2Treatment groups
Active Control
Group I: Intensive Crisis Intervention (ICI)Active Control1 Intervention
ICI is a brief (Average Length of Stay \[ALOS\]: M±SD=4.5±1.4 days), intensive family-centered, skills-based alternative to traditional inpatient psychiatric care. Adolescents participate in 2-3 individual sessions and 1-2 family sessions daily. Based on the cognitive-behavioral model of suicidality, ICI emphasizes that learned, maladaptive cognitive, behavioral, and affective responses to stressors contributing to suicidal behavior can be changed. Master's-level clinicians facilitate this process by engaging adolescents and their families in developing more effective coping skills when faced with potential triggers to suicidal crises.
Group II: Adolescent Psychiatric Inpatient Unit (APIU)Active Control1 Intervention
APIU provides comprehensive assessment and treatment services to children and adolescents with significant psychiatric difficulties and to their families using a multidisciplinary approach. Symptoms and behaviors that led to admission are targeted through a milieu-based model of care and therapeutic group programming. The multidisciplinary treatment team includes a child and adolescent psychiatrist, often in collaboration with an advanced practice provider, psychologist, psychiatric nursing staff including trained mental health specialists, behavioral healthcare clinicians, care managers, rehabilitative care staff, teachers, and parent partners. Average length of stay is 9-11 days. An individualized treatment plan is developed by the entire treatment team, including the patient and caregivers, and includes initial planning for discharge with the primary treatment goal being stabilization of acute psychiatric symptoms. Programming is based on a trauma-informed biopsychosocial approach.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Jennifer Hughes

Lead Sponsor

Trials
2
Recruited
250+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Ohio State University

Collaborator

Trials
891
Recruited
2,659,000+

Findings from Research

The pilot study demonstrated that The Collaborative Assessment and Management of Suicidality (CAMS) is feasible and effective for treating suicidal inpatients, with significant reductions in depression, hopelessness, and suicidal ideation over an average treatment period of 51 days.
With a sample of 20 patients, the intervention showed large treatment effect sizes (Cohen's d > .80), indicating strong potential for CAMS as a structured approach to reduce suicide risk in hospitalized individuals.
Collaborative assessment and management of suicidality in an inpatient setting: results of a pilot study.Ellis, TE., Green, KL., Allen, JG., et al.[2021]
The case study of a 55-year-old housewife who committed suicide after psychiatric inpatient treatment highlights the complexities of managing patients with a history of severe suicide attempts, emphasizing the need for better understanding of their social and psychological contexts.
The therapy team concluded that insights from this tragic case could lead to improved management strategies for inpatient treatment following suicide attempts, suggesting that learning from unsuccessful interventions is crucial for enhancing future care.
Suicide following attempted suicide: a study of an unsuccessful intervention.Etzersdorfer, E.[2022]
A qualitative study involving experienced suicide researchers revealed significant challenges in defining and reporting adverse events (AEs) and serious adverse events (SAEs) in suicide prevention trials, which complicates safety evaluations.
Participants emphasized the urgent need for clear and consistent definitions and reporting standards for AEs and SAEs to improve the comparability of studies and enhance safety monitoring in at-risk populations.
Variability in the definition and reporting of adverse events in suicide prevention trials: an examination of the issues and a proposed solution.Oquendo, MA., Feldman, S., Silverman, E., et al.[2022]

References

Collaborative assessment and management of suicidality in an inpatient setting: results of a pilot study. [2021]
Suicide following attempted suicide: a study of an unsuccessful intervention. [2022]
Innovations in Practice: Intensive crisis intervention for adolescent suicidal ideation and behavior - an open trial. [2020]
Impact of a Suicide-Specific Intervention within Inpatient Psychiatric Care: The Collaborative Assessment and Management of Suicidality. [2022]
Effect of Crisis Response Planning on Patient Mood and Clinician Decision Making: A Clinical Trial With Suicidal U.S. Soldiers. [2022]
Variability in the definition and reporting of adverse events in suicide prevention trials: an examination of the issues and a proposed solution. [2022]
An example of implementing a safety protocol in remote intervention and survey research with college students. [2023]
Analysis of Suicides Reported as Adverse Events in Psychiatry Resulted in Nine Quality Improvement Initiatives. [2022]
Using structured telephone follow-up assessments to improve suicide-related adverse event detection. [2021]
Review: Adverse event monitoring and reporting in studies of pediatric psychosocial interventions: a systematic review. [2023]
[Impact of the suicidal crisis intervention training program on the confidence and skills of hospital professionals in the Hauts-de-France region]. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
Brief and Ultra-Brief Suicide-Specific Interventions. [2023]
13.United Statespubmed.ncbi.nlm.nih.gov
The subacute hospital treatment of the borderline patient: III. Management of suicidal crisis by family intervention. [2022]
[Crisis intervention - Professional first aid in acute crisis]. [2020]
[Crisis intervention in suicidal subjects]. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security